Li ZL - Search Results

1

Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.

Xu XF, Xing H, Han J, Li ZL, Lau WY, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Li C, Wu MC, Shen F, Yang T. Xu XF, et al. Among authors: li c, li zl. JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334. JAMA Surg. 2019. PMID: 30422241 Free PMC article.

2

Hepatocellular carcinoma surveillance: Sometimes just specialists' incidental behavior?

Zhang H, Li ZL, Xing H, Wu MC, Yang T. Zhang H, et al. Among authors: li zl. Hepatology. 2017 Aug;66(2):672. doi: 10.1002/hep.29200. Epub 2017 Jul 4. Hepatology. 2017. PMID: 28387963 No abstract available.

3

Reliability and validity analyses are essential for questionnaire research.

Xing H, Liang L, Li ZL, Zhang H, Yang T. Xing H, et al. Among authors: li zl. Hepatology. 2017 Sep;66(3):1008-1009. doi: 10.1002/hep.29295. Epub 2017 Jul 27. Hepatology. 2017. PMID: 28558127 No abstract available.

4

How to predict global trends in HCC mortality if neglecting more than half the world's cases?

Sun LY, Zhang H, Li ZL, Li C, Wang MD, Yang T. Sun LY, et al. Among authors: li c, li zl. J Hepatol. 2017 Oct;67(4):887-888. doi: 10.1016/j.jhep.2017.05.029. Epub 2017 Jun 13. J Hepatol. 2017. PMID: 28627362 No abstract available.

5

Comparison of Patterns and Outcomes of Liver Resection for Hepatocellular Carcinoma: East vs West.

Yang T, Tabrizian P, Zhang H, Lau WY, Han J, Li ZL, Wang Z, Wu MC, Florman S, Schwartz ME, Shen F. Yang T, et al. Among authors: li zl. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1972-1974. doi: 10.1016/j.cgh.2017.06.025. Epub 2017 Jun 17. Clin Gastroenterol Hepatol. 2017. PMID: 28634137 No abstract available.

6

Surgical site infections following pancreaticoduodenectomy.

Xu XF, Yu JJ, Huang YS, Han J, Li ZL, Zhang H, Yang T. Xu XF, et al. Among authors: li zl. HPB (Oxford). 2017 Dec;19(12):1130. doi: 10.1016/j.hpb.2017.07.014. Epub 2017 Sep 8. HPB (Oxford). 2017. PMID: 28890313 Free article. No abstract available.

7

Surface Nanopore Engineering of 2D MXenes for Targeted and Synergistic Multitherapies of Hepatocellular Carcinoma.

Li Z, Zhang H, Han J, Chen Y, Lin H, Yang T. Li Z, et al. Adv Mater. 2018 Jun;30(25):e1706981. doi: 10.1002/adma.201706981. Epub 2018 Apr 16. Adv Mater. 2018. PMID: 29663543

8

CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.

Dong X, Chen G, Cai Z, Li Z, Qiu L, Xu H, Yuan Y, Liu XL, Liu J. Dong X, et al. Cell Physiol Biochem. 2018;47(6):2602-2612. doi: 10.1159/000491656. Epub 2018 Jul 11. Cell Physiol Biochem. 2018. PMID: 29996118 Free article.

9

Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.

Chen G, Cai Z, Li Z, Dong X, Xu H, Lin J, Chen L, Zhang H, Liu X, Liu J. Chen G, et al. Int J Cancer. 2018 Dec 1;143(11):2862-2870. doi: 10.1002/ijc.31844. Epub 2018 Oct 3. Int J Cancer. 2018. PMID: 30183077

10

Dysregulated fatty acid metabolism in hepatocellular carcinoma.

Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T. Wang M, et al. Hepat Oncol. 2016 Oct;3(4):241-251. doi: 10.2217/hep-2016-0012. Epub 2017 Jun 30. Hepat Oncol. 2016. PMID: 30191046 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,606 results

Search Page

Filters